-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Estrella Immunopharma, Inc. quarterly Deferred Tax Assets, Gross history and growth rate from Q3 2021 to Q4 2022.
- Estrella Immunopharma, Inc. Deferred Tax Assets, Gross for the quarter ending December 31, 2022 was $263K, a 405% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)